About Synnovation Therapeutics
Synnovation Therapeutics is a private company based in Wilmington, Delaware, incorporated in 2021 in Delaware. It has reported $51,999,773 raised in three offerings on Form D since November 2021. Its chief executive is Wenqing Yao.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 8, 2023 | Dec 14, 2023amended Dec 21, 2023 | $15,000,000of $102.4M target | 7 | $2.1M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 17, 2023 | May 24, 2023 | $24,999,998fully sold | 4 | $6.2M | EquityRule 506(b) | Form D ↗ |
| Nov 19, 2021 | Nov 26, 2021 | $11,999,775of $19.9M target | 1 | $11.9M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $51,999,773 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Synnovation Therapeutics's Form D filed Dec 21, 2023.
LW
Liangxing Wu
Executive officer and director
WY
Wenqing Yao
CEO and director
Reid Huber
Director
Also a director at Asher Biotherapeutics and a partner, third rock ventures and director at Terremoto.
TF
Ting Feng
Director